Best Biotechnology Stocks in Healthcare for 2026
Top-ranked Biotechnology stocks within the Healthcare sector. Biotech splits between cash-generative commercial-stage companies and pre-revenue clinical names; Health is unforgiving on cash burn, so runway discipline decides rank.
Biotechnology spans the cash-generative commercial-stage companies and the pre-revenue clinical-stage cohort. Composite scoring is harsh on cash-burning names via the Health pillar (runway, cash to market cap); commercial-stage biotechs surface through the Quality pillar (gross margin, ROIC) and Valuation pillar.
Data as of (updated daily)
Top 20 Biotechnology stocks in Healthcare by composite score
Live results temporarily unavailable. The full screener is at /screener with the Healthcare + Biotechnology filters.
Customise the Healthcare + Biotechnology screen
The full screener applies both filters and lets you stack 30+ more on top: market cap, country, dividend yield, and the four pillar scores.
Open in screener →Explore related pages
Other industries in Healthcare
Browse the hub pages
Methodology: How we score stocks. Data refreshed nightly around 03:30 ET. This page lists the top 20 by composite score within the Biotechnology industry under Healthcare. Use the screener for the full ranked list.